Lucicebtide is under clinical development by Sapience Therapeutics and currently in Phase II for Gastrointestinal Tract Cancer.
Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase I for Irritable Bowel Syndrome.
Experts discuss whether having caffeine first thing in the morning without food is actually harmful to your health. View ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback